found that tumor-infiltrating B cells could present endogenous tumor antigens to CD4+ TIL and change the phenotype of CD4+ TIL in vitro, and the activated tumor-infiltrating B cells were related to the response of activated IFN-γ + CD4 + T cells (32). The gene discussed is CD4; the disease is neoplasm.